- Home
- MBWM vs PHAR Comparison
MBWM vs PHAR Comparison
Compare MBWM & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBWM
- PHAR
- Stock Information
- Founded
- MBWM 1997
- PHAR 1988
- Country
- MBWM United States
- PHAR Netherlands
- Employees
- MBWM N/A
- PHAR N/A
- Industry
- MBWM Major Banks
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- MBWM Finance
- PHAR Health Care
- Exchange
- MBWM Nasdaq
- PHAR Nasdaq
- Market Cap
- MBWM 732.4M
- PHAR 587.5M
- IPO Year
- MBWM 1997
- PHAR N/A
- Fundamental
- Price
- MBWM $44.03
- PHAR $8.31
- Analyst Decision
- MBWM Buy
- PHAR Strong Buy
- Analyst Count
- MBWM 2
- PHAR 3
- Target Price
- MBWM $55.00
- PHAR $30.00
- AVG Volume (30 Days)
- MBWM 68.1K
- PHAR 7.8K
- Earning Date
- MBWM 04-15-2025
- PHAR 03-13-2025
- Dividend Yield
- MBWM 3.21%
- PHAR N/A
- EPS Growth
- MBWM N/A
- PHAR N/A
- EPS
- MBWM 4.93
- PHAR N/A
- Revenue
- MBWM $224,075,000.00
- PHAR $297,200,000.00
- Revenue This Year
- MBWM $8.04
- PHAR $8.26
- Revenue Next Year
- MBWM $4.10
- PHAR $9.73
- P/E Ratio
- MBWM $9.10
- PHAR N/A
- Revenue Growth
- MBWM 2.79
- PHAR 21.15
- 52 Week Low
- MBWM $33.46
- PHAR $6.65
- 52 Week High
- MBWM $52.98
- PHAR $11.30
- Technical
- Relative Strength Index (RSI)
- MBWM 40.15
- PHAR 42.39
- Support Level
- MBWM $43.59
- PHAR $8.03
- Resistance Level
- MBWM $45.69
- PHAR $8.85
- Average True Range (ATR)
- MBWM 1.27
- PHAR 0.33
- MACD
- MBWM 0.07
- PHAR -0.00
- Stochastic Oscillator
- MBWM 32.96
- PHAR 39.67
About MBWM Mercantile Bank Corporation
Mercantile Bank Corp operates as a bank holding company. It provides a variety of commercial banking services to individuals, businesses, governmental units, and other institutions. It provides banking services offering deposit products including checking, savings, and term certificate accounts, and lending products including commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.